The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Ocular Pharmacology and Therapeutics

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jop.2017.0070PMID 28949790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment

  2016cited by this paper
• The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion

  2016cited by this paper
• Prospective Evaluation of Morphological and Functional Changes after Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion

  2015cited by this paper
• Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.

  2014cited by this paper
• Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.

  2014cited by this paper
• Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.

  2014cited by this paper
• Changes in Macular Function after Ozurdex for Retinal Vein Occlusion

  2014cited by this paper
• EFFICACY AND SAFETY OF TWO OR MORE DEXAMETHASONE INTRAVITREAL IMPLANT INJECTIONS FOR TREATMENT OF MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION (SHASTA STUDY)

  2014cited by this paper
• Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study

  2013cited by this paper
• Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.

  2013cited by this paper
• Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion

  2013cited by this paper
• Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion

  2013cited by this paper
• Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.

  2012cited by this paper
• Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.

  2012cited by this paper
• Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.

  2012cited by this paper
• Best practices for treatment of retinal vein occlusion

  2012cited by this paper
• General Pathophysiology of Macular Edema

  2011cited by this paper
• Retinal vein occlusion: beyond the acute event.

  2011cited by this paper
• Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

  2011cited by this paper
• Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

  2010cited by this paper
• Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

  2010cited by this paper
• NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS

  2010cited by this paper
• Management of macular edema from retinal vein occlusions: you can never have too many choices.

  2010cited by this paper
• Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

  2010cited by this paper
• Diabetes and Peripheral Vascular Disease

  2009cited by this paper
• Adult vitreous structure and postnatal changes

  2008cited by this paper
• Diabetes‐associated macrovasculopathy: pathophysiology and pathogenesis

  2007cited by this paper
• Ageing changes in the eye

  2006cited by this paper
• Masterclass series in peripheral arterial disease

  2004cited by this paper
• Vascular risk: diabetes.

  2004cited by this paper
• Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

  2003cited by this paper
• Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire.

  2003cited by this paper
• The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.

  2000cited by this paper
• Vascular homeostasis, adhesion molecules, and macrovascular disease in non‐insulin‐dependent diabetes mellitus

  1997cited by this paper
• Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report.

  1995cited by this paper
• Role of Blood Flow and Impaired Autoregulation in the Pathogenesis of Diabetic Retinopathy

  1995cited by this paper
• Diabetes and peripheral vascular disease.

  1992cited by this paper
• Argon laser photocoagulation for macular edema in branch vein occlusion.

  1986cited by this paper
• Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

  1984cited by this paper
• [Vascular risk in diabetes].

  1973cited by this paper

• Clinical Features of Central Retinal Vein Occlusion in Young Patients

  2022cites this paper
• Short-term effectiveness prognostic factors after dexamethasone intravitreal implant in macular edema due to retinal vein occlusion

  2021cites this paper
• Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion

  2021cites this paper
• Safety and effectiveness of intravitreal injection of dexamethasone for macular edema secondary to retinal vein occlusion: a meta-analysis

  2020cites this paper
• Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review

  2020cites this paper
• OPTH_A_264559 3097..3108

  2020cites this paper
• Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)

  2019cites this paper